Abstract
Summary: Background: ProvenIgEorT‐cell mediated drug hypersensitivity reactions (DHRs) seem less common in children compared with adults. However, this has never been proved by data.Objective: To determine and compare provenDHRprevalence in children and adults.Methods: Using theDAHD(DrugAllergy andHypersensitivityDatabase) cohort, children with provenDHRs were compared with adults. The internationalEAACI‐ENDArecommendations were followed. Patients were divided into four groups: index reaction and test during childhood (C/C), index reaction at childhood and test at adulthood (C/A), index reactions at childhood and adulthood and test at adulthood (CA/A), index reaction and test at adulthood (A/A).Results: A total of 3275 patients (67.9% female), comprising a total of 4370 patient‐episodes, were evaluated (74.5% belonged to theA/Agroup). Prevalence of positive tests was 15.2% (95%CI, 14.1–16.2) for all tested classes, 10.6% (8.3–13.0) forC/C, 10.6% (7.5–13.6) forC/A, 22.1% (12.8–31.3) forCA/Aand 16.5% (15.2–17.8) forA/A. The prevalence was lower in groupC/Ccompared with groupsA/A(P < 0.0001) andCA/A(P = 0.003). It was also lower in groupC/Acompared with the two latter groups (respectivelyP = 0.003 andP = 0.005). Significant differences were found for maculopapular exanthemas only, and not for urticaria/angiœdema and anaphylaxis. The difference was mainly observed with β‐lactams and not forNSAIDs.Conclusion and Clinical Relevance: Suspicions of DHRs are less likely to be confirmed in children.

This publication has 21 references indexed in Scilit: